American Vietnamese Biotech Incorporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, revenue was VND 97,810.66 million compared to VND 126,817.35 million a year ago. Net income was VND 5,229.41 million compared to VND 46,115.24 million a year ago. Basic earnings per share from continuing operations was VND 40 compared to VND 479 a year ago. Diluted earnings per share from continuing operations was VND 40 compared to VND 479 a year ago.